{"id":165621,"date":"2023-08-08T22:24:46","date_gmt":"2023-08-08T14:24:46","guid":{"rendered":"https:\/\/www.chinapulse.com\/?p=521302"},"modified":"2023-08-08T22:24:46","modified_gmt":"2023-08-08T14:24:46","slug":"biggest-stock-movers-today-novavax-eli-lilly-tilray-brands-medical-properties-and-more","status":"publish","type":"post","link":"https:\/\/www.chinalegalblog.com\/en\/2023\/08\/08\/biggest-stock-movers-today-novavax-eli-lilly-tilray-brands-medical-properties-and-more\/","title":{"rendered":"Biggest stock movers today: Novavax, Eli Lilly, Tilray Brands, Medical Properties and more"},"content":{"rendered":"<p>Stock futures fell during Tuesday&#8217;s session following weak Chinese trade data and renewed concerns about the health of the U.S. banks.<\/p>\n<p>Here are some of Tuesday&#8217;s biggest stock movers:<\/p>\n<p>Biggest stock gainers<\/p>\n<p>Eli Lilly&#8217;s ( NYSE: LLY increased by 9% after the company reported better than expected Q2 results led by diabetes therapy Mounjaro and raised its full-year guidance ahead of expectations.&#8230;<\/p>\n<p>This data comes from the <a href=\"https:\/\/www.chinapulse.com\/\" title=\"ChinaPulse.com provides Media Intelligence and Media Monitoring in China\" >ChinaPulse.com media intelligence and smart news insights monitoring platform<\/a>.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Stock futures fell during Tuesday's session following weak Chinese trade data and renewed concerns about the health of the U.S. banks.<br \/>\nHere are some of Tuesday's biggest stock movers:<br \/>\nBiggest stock gainers<br \/>\nEli Lilly's ( NYSE: LLY incr&#8230;<\/p>\n","protected":false},"author":250,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[669,692,213,288,194,1284],"tags":[2762,10548,3472,5256,7327],"class_list":["post-165621","post","type-post","status-publish","format-standard","hentry","category-bank","category-canada","category-china-news","category-medicine","category-news-chinese-law","category-stock-market","tag-acquisition","tag-cannabis","tag-chinese","tag-healthcare","tag-revenue"],"_links":{"self":[{"href":"https:\/\/www.chinalegalblog.com\/en\/wp-json\/wp\/v2\/posts\/165621","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.chinalegalblog.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.chinalegalblog.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.chinalegalblog.com\/en\/wp-json\/wp\/v2\/users\/250"}],"replies":[{"embeddable":true,"href":"https:\/\/www.chinalegalblog.com\/en\/wp-json\/wp\/v2\/comments?post=165621"}],"version-history":[{"count":1,"href":"https:\/\/www.chinalegalblog.com\/en\/wp-json\/wp\/v2\/posts\/165621\/revisions"}],"predecessor-version":[{"id":165622,"href":"https:\/\/www.chinalegalblog.com\/en\/wp-json\/wp\/v2\/posts\/165621\/revisions\/165622"}],"wp:attachment":[{"href":"https:\/\/www.chinalegalblog.com\/en\/wp-json\/wp\/v2\/media?parent=165621"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.chinalegalblog.com\/en\/wp-json\/wp\/v2\/categories?post=165621"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.chinalegalblog.com\/en\/wp-json\/wp\/v2\/tags?post=165621"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}